The "treat-to-target" strategies for rheumatoid arthritis and managing for bone cartilage destructions

研究成果: Article査読

抄録

Sometime ago, there was little choice for the treatment of rheumatoid arthritis(RA)that was regarded as an untreateble disease but supportive analgesics and mild disease modified drugs. The advent of biological agents with abundant clinical researches regarding remarkable efficacy has cased dramatically the paradigm shift in the treatment of RA. The strategy for medical care to RA has now entered a new era in that treatment target should be clarified and shared between patient and rheumatologist aiming the prevention of structural damage and the maintain of long-term quality of life(QOL)by tight-control. In this review, we summarize the "treat to target"(T2T)strategies for RA and its impact to manage for bone and cartilage destructions.

本文言語English
ページ(範囲)1757-1762
ページ数6
ジャーナルClinical calcium
25
12
出版ステータスPublished - 2015 12 1

ASJC Scopus subject areas

  • Medicine(all)

フィンガープリント 「The "treat-to-target" strategies for rheumatoid arthritis and managing for bone cartilage destructions」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル